Hormone replacement therapy (HRT) may leads to lower overall survival compared with no HRT (low certainty).
Hormone replacement therapy (HRT) showed no clear difference in progression‐free survival compared with no HRT (low certainty).
It is very uncertain whether hormone replacement therapy (HRT) changes incidence of breast cancer compared with no HRT (very low certainty).
It is very uncertain whether hormone replacement therapy (HRT) changes incidence of transient ischaemic attack compared with no HRT (very low certainty).
It is very uncertain whether hormone replacement therapy (HRT) changes incidence of cerebrovascular accident compared with no HRT (very low certainty).
It is very uncertain whether hormone replacement therapy (HRT) changes incidence of myocardial infarction compared with no HRT (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether oestrogen replacement therapy changes rate of tumour recurrence compared with placebo (very low certainty).
It is very uncertain whether oestrogen replacement therapy changes rate of appearance of a new malignancy compared with placebo (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.